These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2572198)

  • 1. Preliminary evidence for inhibitory effect of glycyrrhizin on HIV replication in patients with AIDS.
    Hattori T; Ikematsu S; Koito A; Matsushita S; Maeda Y; Hada M; Fujimaki M; Takatsuki K
    Antiviral Res; 1989; 11(5-6):255-61. PubMed ID: 2572198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of glycyrrhizin (SNMC: stronger Neo-Minophagen C) in hemophilia patients with HIV infection.
    Mori K; Sakai H; Suzuki S; Sugai K; Akutsu Y; Ishikawa M; Seino Y; Ishida N; Uchida T; Kariyone S
    Tohoku J Exp Med; 1989 May; 158(1):25-35. PubMed ID: 2781539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of glycyrrhizin (SNMC: Stronger Neo-Minophagen C) in hemophilia patients with HIV-1 infection.
    Mori K; Sakai H; Suzuki S; Akutsu Y; Ishikawa M; Imaizumi M; Tada K; Aihara M; Sawada Y; Yokoyama M
    Tohoku J Exp Med; 1990 Oct; 162(2):183-93. PubMed ID: 2129071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS).
    Krown SE; Gold JW; Niedzwiecki D; Bundow D; Flomenberg N; Gansbacher B; Brew BJ
    Ann Intern Med; 1990 Jun; 112(11):812-21. PubMed ID: 1971504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia.
    MacDonell KB; Chmiel JS; Poggensee L; Wu S; Phair JP
    Am J Med; 1990 Dec; 89(6):706-12. PubMed ID: 1979205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive markers for the acquired immunodeficiency syndrome (AIDS) in hemophiliacs: persistence of p24 antigen and low T4 cell count.
    Eyster ME; Ballard JO; Gail MH; Drummond JE; Goedert JJ
    Ann Intern Med; 1989 Jun; 110(12):963-9. PubMed ID: 2567142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia.
    Goedert JJ; Kessler CM; Aledort LM; Biggar RJ; Andes WA; White GC; Drummond JE; Vaidya K; Mann DL; Eyster ME
    N Engl J Med; 1989 Oct; 321(17):1141-8. PubMed ID: 2477702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of human immunodeficiency viral replication by pine cone extracts.
    Lai PK; Donovan J; Takayama H; Sakagami H; Tanaka A; Konno K; Nonoyama M
    AIDS Res Hum Retroviruses; 1990 Feb; 6(2):205-17. PubMed ID: 1691654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV).
    Ito M; Sato A; Hirabayashi K; Tanabe F; Shigeta S; Baba M; De Clercq E; Nakashima H; Yamamoto N
    Antiviral Res; 1988 Dec; 10(6):289-98. PubMed ID: 3250333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAP 30: a new inhibitor of HIV-1 infection and replication.
    Lee-Huang S; Huang PL; Nara PL; Chen HC; Kung HF; Huang P; Huang HI; Huang PL
    FEBS Lett; 1990 Oct; 272(1-2):12-8. PubMed ID: 1699801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 sensitivity to zidovudine and clinical outcome in children.
    Tudor-Williams G; St Clair MH; McKinney RE; Maha M; Walter E; Santacroce S; Mintz M; O'Donnell K; Rudoll T; Vavro CL
    Lancet; 1992 Jan; 339(8784):15-9. PubMed ID: 1345951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The present status in prophylaxis and treatment of HIV infected patients with hemophilia in Japan].
    Mori K; Sakai H; Suzuki S; Akutsu Y; Ishikawa M; Aihara M; Yokoyama M; Sato Y; Okaniwa S; Endo Y
    Rinsho Byori; 1989 Nov; 37(11):1200-8. PubMed ID: 2689699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year evaluation of clinical and laboratory variables of immune function in 117 hemophiliacs seropositive or seronegative for HIV-1.
    Teitel JM; Freedman JJ; Garvey MB; Kardish M
    Am J Hematol; 1989 Dec; 32(4):262-72. PubMed ID: 2573270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of infectious immune complexes in human immunodeficiency virus type 1 (HIV-1) infections: correlation with plasma viremia and CD4 cell counts.
    Fiscus SA; Wallmark EB; Folds JD; Fryer J; van der Horst CM
    J Infect Dis; 1991 Oct; 164(4):765-9. PubMed ID: 1680137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus isolates from asymptomatic homosexual men and from AIDS patients have distinct biologic and genetic properties.
    Balachandran R; Thampatty P; Enrico A; Rinaldo C; Gupta P
    Virology; 1991 Jan; 180(1):229-38. PubMed ID: 1701946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation.
    Dis Markers; 1990; 8(3):162-3. PubMed ID: 2125537
    [No Abstract]   [Full Text] [Related]  

  • 17. Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1.
    Sperber K; Louie M; Kraus T; Proner J; Sapira E; Lin S; Stecher V; Mayer L
    Clin Ther; 1995; 17(4):622-36. PubMed ID: 8565026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 7-year analysis of anti-Gag (p17 and p24) antibodies in HIV-1-seropositive patients with haemophilia: immunoglobulin G titre and avidity are early predictors of clinical course.
    Chargelegue D; Colvin BT; O'Toole CM
    AIDS; 1993 Nov; 7 Suppl 2():S87-90. PubMed ID: 7909231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term zidovudine treatment of asymptomatic HIV-1-infected subjects.
    Mulder JW; de Wolf F; Goudsmit J; Cload PA; Coutinho RA; Fiddian AP; Schellekens PT; van der Noordaa J; Lange JM
    Antiviral Res; 1990 Mar; 13(3):127-38. PubMed ID: 1972321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS.
    Levacher M; Tallet S; Dazza MC; Dournon E; Rouveix B; Pocidalo JJ
    Clin Exp Immunol; 1990 Aug; 81(2):177-82. PubMed ID: 1696859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.